Growth Metrics

Novartis Ag (NVS) Property, Plant & Equipment (Gross) (2016 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Gross) (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn -
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn 54.70 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn -
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn -
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn -
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 8.42 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn -
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn 13.09 Bn
10 Gsk 88.34 Bn 83.66 Bn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2025 10.38 Bn
Jun 30, 2025 10.38 Bn
Dec 31, 2024 20.00 Mn
Dec 31, 2024 20.00 Mn
Sep 30, 2024 17.00 Mn
Sep 30, 2024 17.00 Mn
Jun 30, 2024 9.25 Bn
Jun 30, 2024 9.25 Bn
Mar 31, 2024 219.00 Mn
Mar 31, 2024 219.00 Mn
Dec 31, 2023 18.00 Mn
Dec 31, 2023 18.00 Mn
Jun 30, 2023 10.83 Bn
Jun 30, 2023 10.83 Bn
Mar 31, 2023 252.00 Mn
Mar 31, 2023 252.00 Mn
Dec 31, 2022 10.76 Bn
Dec 31, 2022 10.76 Bn
Sep 30, 2022 13.00 Mn
Sep 30, 2022 13.00 Mn
Jun 30, 2022 10.76 Bn
Jun 30, 2022 10.76 Bn
Mar 31, 2022 13.00 Mn
Mar 31, 2022 13.00 Mn
Dec 31, 2021 11.55 Bn
Dec 31, 2021 11.55 Bn
Jun 30, 2021 11.55 Bn
Jun 30, 2021 11.55 Bn
Dec 31, 2020 26.00 Mn
Dec 31, 2020 26.00 Mn
Jun 30, 2020 12.26 Bn
Jun 30, 2020 12.26 Bn
Mar 31, 2020 26.00 Mn
Mar 31, 2020 26.00 Mn
Dec 31, 2019 169.00 Mn
Dec 31, 2019 169.00 Mn
Jun 30, 2019 44.00 Mn
Jun 30, 2019 44.00 Mn
Dec 31, 2018 15.70 Bn
Dec 31, 2018 15.70 Bn
Jun 30, 2018 15.96 Bn
Jun 30, 2018 15.96 Bn
Dec 31, 2017 16.46 Bn
Dec 31, 2017 16.46 Bn
Dec 31, 2016 15.64 Bn
Dec 31, 2016 15.64 Bn